These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 21327452)

  • 1. Overexpression of Galectin-3 and its clinical significance in ovarian carcinoma.
    Kim MK; Sung CO; Do IG; Jeon HK; Song TJ; Park HS; Lee YY; Kim BG; Lee JW; Bae DS
    Int J Clin Oncol; 2011 Aug; 16(4):352-8. PubMed ID: 21327452
    [TBL] [Abstract][Full Text] [Related]  

  • 2. FOXM1 expression is significantly associated with chemotherapy resistance and adverse prognosis in non-serous epithelial ovarian cancer patients.
    Tassi RA; Todeschini P; Siegel ER; Calza S; Cappella P; Ardighieri L; Cadei M; Bugatti M; Romani C; Bandiera E; Zanotti L; Tassone L; Guarino D; Santonocito C; Capoluongo ED; Beltrame L; Erba E; Marchini S; D'Incalci M; Donzelli C; Santin AD; Pecorelli S; Sartori E; Bignotti E; Odicino F; Ravaggi A
    J Exp Clin Cancer Res; 2017 May; 36(1):63. PubMed ID: 28482906
    [TBL] [Abstract][Full Text] [Related]  

  • 3. High galectin-1 expression correlates with poor prognosis and is involved in epithelial ovarian cancer proliferation and invasion.
    Kim HJ; Jeon HK; Cho YJ; Park YA; Choi JJ; Do IG; Song SY; Lee YY; Choi CH; Kim TJ; Bae DS; Lee JW; Kim BG
    Eur J Cancer; 2012 Aug; 48(12):1914-21. PubMed ID: 22386573
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Galectin-3 regulates metastatic capabilities and chemotherapy sensitivity in epithelial ovarian carcinoma via NF-κB pathway.
    Lu H; Liu Y; Wang D; Wang L; Zhou H; Xu G; Xie L; Wu M; Lin Z; Yu Y; Li G
    Tumour Biol; 2016 Aug; 37(8):11469-77. PubMed ID: 27012551
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Galectins-1, -3, and -7 Are Prognostic Markers for Survival of Ovarian Cancer Patients.
    Schulz H; Schmoeckel E; Kuhn C; Hofmann S; Mayr D; Mahner S; Jeschke U
    Int J Mol Sci; 2017 Jun; 18(6):. PubMed ID: 28594391
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Galectin-3 regulates chemotherapy sensitivity in epithelial ovarian carcinoma via regulating mitochondrial function.
    Wang D; You D; Li L
    J Toxicol Sci; 2019; 44(1):47-56. PubMed ID: 30626779
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pectasol-C Modified Citrus Pectin targets Galectin-3-induced STAT3 activation and synergize paclitaxel cytotoxic effect on ovarian cancer spheroids.
    Hossein G; Halvaei S; Heidarian Y; Dehghani-Ghobadi Z; Hassani M; Hosseini H; Naderi N; Sheikh Hassani S
    Cancer Med; 2019 Aug; 8(9):4315-4329. PubMed ID: 31197964
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical significance of galectin-7 in epithelial ovarian cancer.
    Kim HJ; Jeon HK; Lee JK; Sung CO; Do IG; Choi CH; Kim TJ; Kim BG; Bae DS; Lee JW
    Anticancer Res; 2013 Apr; 33(4):1555-61. PubMed ID: 23564797
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Vascular endothelial growth factor C enhances cervical cancer cell invasiveness via upregulation of galectin-3 protein.
    Liu J; Cheng Y; He M; Yao S
    Gynecol Endocrinol; 2014 Jun; 30(6):461-5. PubMed ID: 24650367
    [TBL] [Abstract][Full Text] [Related]  

  • 10. High claudin-7 expression is associated with a poor response to platinum-based chemotherapy in epithelial ovarian carcinoma.
    Kim CJ; Lee JW; Choi JJ; Choi HY; Park YA; Jeon HK; Sung CO; Song SY; Lee YY; Choi CH; Kim TJ; Lee JH; Kim BG; Bae DS
    Eur J Cancer; 2011 Apr; 47(6):918-25. PubMed ID: 21134740
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Elevated nm23 protein expression is correlated with diminished progression-free survival in patients with epithelial ovarian carcinoma.
    Srivatsa PJ; Cliby WA; Keeney GL; Dodson MK; Suman VJ; Roche PC; Podratz KC
    Gynecol Oncol; 1996 Mar; 60(3):363-72. PubMed ID: 8774640
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Overexpression of the recently identified oncogene REDD1 correlates with tumor progression and is an independent unfavorable prognostic factor for ovarian carcinoma.
    Chang B; Meng J; Zhu H; Du X; Sun L; Wang L; Li S; Yang G
    Diagn Pathol; 2018 Nov; 13(1):87. PubMed ID: 30428884
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Galectin-3 expression is prognostic in diffuse type gastric adenocarcinoma, confers aggressive phenotype, and can be targeted by YAP1/BET inhibitors.
    Ajani JA; Estrella JS; Chen Q; Correa AM; Ma L; Scott AW; Jin J; Liu B; Xie M; Sudo K; Shiozaki H; Badgwell B; Weston B; Lee JH; Bhutani MS; Onodera H; Suzuki K; Suzuki A; Ding S; Hofstetter WL; Johnson RL; Bresalier RS; Song S
    Br J Cancer; 2018 Jan; 118(1):52-61. PubMed ID: 29136404
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression and functions of galectin-7 in ovarian cancer.
    Labrie M; Vladoiu MC; Grosset AA; Gaboury L; St-Pierre Y
    Oncotarget; 2014 Sep; 5(17):7705-21. PubMed ID: 25277199
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Upregulation of centrosomal protein 55 is associated with unfavorable prognosis and tumor invasion in epithelial ovarian carcinoma.
    Zhang W; Niu C; He W; Hou T; Sun X; Xu L; Zhang Y
    Tumour Biol; 2016 May; 37(5):6239-54. PubMed ID: 26615423
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Proton pump inhibitors enhance the effects of cytotoxic agents in chemoresistant epithelial ovarian carcinoma.
    Lee YY; Jeon HK; Hong JE; Cho YJ; Ryu JY; Choi JJ; Lee SH; Yoon G; Kim WY; Do IG; Kim MK; Kim TJ; Choi CH; Lee JW; Bae DS; Kim BG
    Oncotarget; 2015 Oct; 6(33):35040-50. PubMed ID: 26418900
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Defective expression of Protein 4.1N is correlated to tumor progression, aggressive behaviors and chemotherapy resistance in epithelial ovarian cancer.
    Xi C; Ren C; Hu A; Lin J; Yao Q; Wang Y; Gao Z; An X; Liu C
    Gynecol Oncol; 2013 Dec; 131(3):764-71. PubMed ID: 23994105
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Expression and significance of PD-1 and PD-L1 in the specimens of epithelial ovarian cancer].
    Ju C; Gao JC; Zhang PX; Zhang KN; Yang S; Kang TJ; Zhao HZ; Qi WJ; Zhang QP; Kong FD; Guan HW; Shi H
    Zhonghua Fu Chan Ke Za Zhi; 2020 Aug; 55(8):529-534. PubMed ID: 32854477
    [No Abstract]   [Full Text] [Related]  

  • 19. CDKN3 is an independent prognostic factor and promotes ovarian carcinoma cell proliferation in ovarian cancer.
    Li T; Xue H; Guo Y; Guo K
    Oncol Rep; 2014 Apr; 31(4):1825-31. PubMed ID: 24573179
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differential expression of galectin-3 in pituitary tumors.
    Riss D; Jin L; Qian X; Bayliss J; Scheithauer BW; Young WF; Vidal S; Kovacs K; Raz A; Lloyd RV
    Cancer Res; 2003 May; 63(9):2251-5. PubMed ID: 12727847
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.